Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$657M |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$587M |
| 4 |
AstraZeneca
AZN
|
+$319M |
| 5 |
Snowflake
SNOW
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$323M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$273M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$121M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$98.6M |
| 5 |
JD.com
JD
|
+$89.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.03% |
| 2 | Financials | 13.72% |
| 3 | Healthcare | 12.6% |
| 4 | Consumer Discretionary | 10.97% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZYXI
2401
DELISTED
Zynex
ZYXI
| $514K | ﹤0.01% |
49,642
+5,162
| +12% | +$66.4K |
|
|
AGEN
2402
Agenus
AGEN
$290M
| $511K | ﹤0.01% |
4,956
+1,800
| +57% | +$203K |
|
2403
Gaotu Techedu
GOTU
$436M
| $509K | ﹤0.01% |
165,832
+48,202
| +41% | +$243K |
|
|
ATCO
2404
DELISTED
Atlas Corp.
ATCO
| $507K | ﹤0.01% |
33,402
-22,108
| -40% | -$316K |
|
|
CELL
2405
DELISTED
PhenomeX Inc. Common Stock
CELL
| $506K | ﹤0.01% |
25,867
+35
| +0.1% | +$1.33K |
|
2406
Afya
AFYA
$1.27B
| $504K | ﹤0.01% |
25,517
+11,292
| +79% | +$256K |
|
2407
Santander
BSBR
$43.5B
| $502K | ﹤0.01% |
80,179
| – | – |
|
|
DNMR
2408
DELISTED
Danimer Scientific, Inc.
DNMR
| $502K | ﹤0.01% |
768
+487
| +173% | +$358K |
|
|
MODN
2409
DELISTED
MODEL N, INC.
MODN
| $502K | ﹤0.01% |
14,981
+6,278
| +72% | +$212K |
|
|
RDUS
2410
DELISTED
Radius Recycling
RDUS
| $496K | ﹤0.01% |
11,312
+5,117
| +83% | +$247K |
|
2411
International Money Express
IMXI
$367M
| $489K | ﹤0.01% |
29,263
+15,063
| +106% | +$252K |
|
2412
Blink Charging
BLNK
$87.9M
| $487K | ﹤0.01% |
17,006
+7,414
| +77% | +$240K |
|
2413
iShares Core S&P Mid-Cap ETF
IJH
$127B
| $487K | ﹤0.01% |
9,250
-3,750
| -29% | -$202K |
|
|
SGMO
2414
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $485K | ﹤0.01% |
53,820
+23,912
| +80% | +$236K |
|
2415
OceanFirst Financial
OCFC
$1.91B
| $481K | ﹤0.01% |
22,466
+11,935
| +113% | +$245K |
|
|
ONT
2416
Onterris Inc
ONT
$580M
| $480K | ﹤0.01% |
7,783
+4,539
| +140% | +$237K |
|
|
CDMO
2417
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $480K | ﹤0.01% |
22,240
+11,960
| +116% | +$289K |
|
2418
IAMGOLD
IAG
$10.5B
| $479K | ﹤0.01% |
211,600
-147,907
| -41% | -$369K |
|
2419
TriCo Bancshares
TCBK
$1.83B
| $478K | ﹤0.01% |
11,021
+5,938
| +117% | +$240K |
|
2420
Vera Bradley
VRA
$98.7M
| $477K | ﹤0.01% |
50,680
+5,438
| +12% | +$59.6K |
|
|
CERE
2421
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $475K | ﹤0.01% |
16,118
+9,821
| +156% | +$276K |
|
|
RDUS
2422
DELISTED
Radius Health, Inc.
RDUS
| $475K | ﹤0.01% |
38,286
+7,768
| +25% | +$112K |
|
2423
Clear Channel Outdoor Holdings
CCO
$1.23B
| $474K | ﹤0.01% |
174,800
+117,589
| +206% | +$294K |
|
2424
Levi Strauss
LEVI
$9.39B
| $474K | ﹤0.01% |
19,324
+16,494
| +583% | +$445K |
|
2425
First Busey Corp
BUSE
$2.56B
| $473K | ﹤0.01% |
19,209
+9,837
| +105% | +$232K |
|
Similar funds
Legal & General Group's Q3 2021 Portfolio in Review
As of Q3 2021, Legal & General Group held 3,551 positions worth $308B, up 2.9% from $299B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Legal & General Group deployed $10.7B of net new capital in Q3 2021, opening 77 new positions and adding to 2,293 existing holdings. Its largest new stake was AstraZeneca: 2,738,007 shares worth $329M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was JD.com, an estimated $89.3M trimmed.
- Legal & General Group's largest Q3 2021 buy was AstraZeneca: 2,738,007 shares worth $329M.
- Legal & General Group added most to Microsoft in Q3 2021, an estimated $657M increase.
- Legal & General Group's biggest Q3 2021 reduction was JD.com, cutting an estimated $89.3M.
- Legal & General Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $323M.
- Legal & General Group's ten largest holdings make up 22% of its $308B portfolio in Q3 2021.
- Legal & General Group opened 77 new positions and closed 55 in Q3 2021.
- Legal & General Group's portfolio value rose 2.9% quarter-over-quarter to $308B.
Based on Legal & General Group's 13F filing for Q3 2021, filed 15 Nov 2021.